Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Salvage Therapy with Intravenous Liposomal Adryamicin (A), Bortezomib (B), Cyclophosphamide (C), and Dexamethasone (D) (ABCD) in Previously Treated Myeloma Patients

Francesco Di Raimondo, Alessandra Romano, Ausilia Gorgone, Annalisa Chiarenza, Maide Cavalli, Salvatore Berretta, Paolo Fiumara, Giovanna Motta, Giuseppe A. Palumbo

Blood (2008) 112 (11): 2779.

https://doi.org/10.1182/blood.V112.11.2779.2779

Published: 2008

Journal Articles

Role of Imatinib Mesylate in Osteoblastogenesis.

Daniele Tibullo, PhD, Cesarina Giallongo, PhD, Piera La Cava, PhD, Salvatore Berretta, MD, Fabio Stagno, MD, Annalisa Chiarenza, MD, Giuseppe A. Palumbo, MD, Francesco Di Raimondo, MD

Blood (2007) 110 (11): 1928.

https://doi.org/10.1182/blood.V110.11.1928.1928

Published: 2007

Journal Articles

Effect of Hypoxia on the Expression of BRIT1 in K562 Cell Line: Implication for Resistance to Imatinib.

Cesarina Giallongo, PhD, Daniele Tibullo, PhD, Piera La Cava, PhD, Annalisa Chiarenza, MD, Salvatore Berretta, MD, Giuseppe A. Palumbo, MD, Francesco Di Raimondo, MD

Blood (2007) 110 (11): 4530.

https://doi.org/10.1182/blood.V110.11.4530.4530

Published: 2007

Journal Articles

CD200 Expression May Help in Differential Diagnosis between Mantle Cell Lymphoma (MCL) and B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Giuseppe A. Palumbo, MD, PhD, Giovanna Forgione, MSc, Nunzia Parrinello, MSc, Katia Cardillo, MSc, Annalisa Chiarenza, MD, Salvatore Berretta, MD, Fabio Stagno, MD, Loredana Villari, MD, Francesco Di Raimondo, MD

Blood (2007) 110 (11): 4672.

https://doi.org/10.1182/blood.V110.11.4672.4672

Published: 2007

Journal Articles

Hypoxia Induces Imatinib Resistance in CML Cell Lines.

Daniela Buglio, MD, Piera La Cava, MSc, Fabio Stagno, MD, Annalisa Chiarenza, MD, Salvatore Berretta, MD, Alesandra Aloisi, MSc, Giuseppe A. Palumbo, MD, Paolo Vigneri, MD, Francesco Di Raimondo, MD

Blood (2006) 108 (11): 4387.

https://doi.org/10.1182/blood.V108.11.4387.4387

Published: 2006

Journal Articles

In Vitro Cytotoxicity of Alemtuzumab on B-CLL Cells: Differential Effect on B and T Lymphocytes.

Salvatore Berretta, MD, Annalisa Chiarenza, MD, Luana Adamo, MS, Laura Parrinello, MS, Daniela Buglio, MD, Fabio Stagno, MD, Daniele Tibullo, MS, Concetta Conticello, MD, PhD, Giuseppe A. Palumbo, MD, PhD, Francesco Di Raimondo, MD

Blood (2006) 108 (11): 4981.

https://doi.org/10.1182/blood.V108.11.4981.4981

Published: 2006

NARROW

Salvage Therapy with Intravenous Liposomal Adryamicin (A), Bortezomib (B), Cyclophosphamide (C), and Dexamethasone (D) (ABCD) in Previously Treated Myeloma Patients

Role of Imatinib Mesylate in Osteoblastogenesis.

Effect of Hypoxia on the Expression of BRIT1 in K562 Cell Line: Implication for Resistance to Imatinib.

CD200 Expression May Help in Differential Diagnosis between Mantle Cell Lymphoma (MCL) and B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Hypoxia Induces Imatinib Resistance in CML Cell Lines.

In Vitro Cytotoxicity of Alemtuzumab on B-CLL Cells: Differential Effect on B and T Lymphocytes.

Email alerts

ASH Publications

American Society of Hematology

Salvage Therapy with Intravenous Liposomal Adryamicin (A), Bortezomib (B), Cyclophosphamide (C), and Dexamethasone (D) (ABCD) in Previously Treated Myeloma Patients

Role of Imatinib Mesylate in Osteoblastogenesis.

Effect of Hypoxia on the Expression of BRIT1 in K562 Cell Line: Implication for Resistance to Imatinib.

CD200 Expression May Help in Differential Diagnosis between Mantle Cell Lymphoma (MCL) and B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Hypoxia Induces Imatinib Resistance in CML Cell Lines.

In Vitro Cytotoxicity of Alemtuzumab on B-CLL Cells: Differential Effect on B and T Lymphocytes.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only